BusinessA New Study Published in The Annals of Thoracic Surgery: Daxor’s BVA-100 Device Reveals Unexpected Blood Loss of 38% in Cardiac Surgical Patients Not Detected by Common Test in UseBy Nasdaq OMXApr 19, 2018, 1:01 PM UTC
